Clinical Trial Update: Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 [Phase 4]

View source ↗

Summary

The Phase 4 Limited Access Protocol study PO2095 evaluating posaconazole for invasive fungal infections has been terminated, with no further enrollment or data …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• NOXAFIL (POSACONAZOLE)

Snippet

Sponsor: University of Pittsburgh | Conditions: Fungal Infection | Phase 4 | Status: TERMINATED